The lack of early-stage capital and de-risking support is a major challenge in advancing promising biomedical technologies from research labs to commercial partners. Federal agencies are stepping up to support innovators who take on the hardest challenges in emerging, transformative biomedical and health technologies. In this funding environment, start-up companies are increasingly looking to bridge the “valley of death” with federal in-kind resources and funding. Likewise, academic accelerator programs and gap funds are also looking for federal partnerships to support de-risking efforts.
The all- Federal panel will provide the audience with a guided tour of their respective agency programs. Each panelist will provide a briefing of how their program is positioned to partner with stakeholders and educate the audience on upcoming funding opportunities. Participating panelists can expect to forge new and on-going partnerships, and to create a setting for productive dialogue with members of the academic and entrepreneurial community in the biomedical arena.
Agenda
10:30 AM – 11:00 AM: Registration
11:00 AM – 12:30 PM: NIA Presentation on SBIR Programs and Funding Announcements
Todd Haim – Director of the Office of Strategic Extramural Programs National Institute on Aging
12:30 PM – 01:00 PM: Lunch
01:00 PM – 02:40 PM: Panel Discussion With Agency Representatives
Corinne Peek-Asa (Moderator) – Vice Chancellor for Research and Innovation, UC San Diego
02:40 PM – 02:50 PM: Coffee break
02:50 PM – 04:05 PM: Agency Presentations
Lauren Nguyen-Antczak – Senior Technology Transfer Manager, NCI Technology Transfer Center & NIH SEED Office (detailee)
Jeffrey Summers, Associate Director, Translational Sciences and Acting Associate Director, Office of Oncologic Diseases Center for Drug Evaluation and Research, US Food and Drug Administration
3:15 PM – 05:00 PM: Agency Break-out Sessions
05:00 PM: Close